{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:14:57Z","timestamp":1787066097984,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005192","name":"California HIV\/AIDS Research Program","doi-asserted-by":"publisher","award":["EI11-SD-005B"],"award-info":[{"award-number":["EI11-SD-005B"]}],"id":[{"id":"10.13039\/100005192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005192","name":"California HIV\/AIDS Research Program","doi-asserted-by":"publisher","award":["E111-LA-002B"],"award-info":[{"award-number":["E111-LA-002B"]}],"id":[{"id":"10.13039\/100005192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017823","name":"Center for AIDS Research, University of California Los Angeles","doi-asserted-by":"publisher","award":["5P30AI028697"],"award-info":[{"award-number":["5P30AI028697"]}],"id":[{"id":"10.13039\/100017823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TR001444"],"award-info":[{"award-number":["TR001444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heterosexual sex accounts for 87% of new HIV diagnoses among cisgender women. We sought to explore the intersection of partner dynamics and oral preexposure prophylaxis (PrEP) adherence among cisgender women in heterosexual serodiscordant relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From June 2017-August 2018, we conducted semi-structured in-depth interviews using a social ecological model framework. Twenty cisgender women in serodiscordant relationships, who participated in a PrEP demonstration project to evaluate adherence and retention in San Diego and Los Angeles, participated in in-depth interviews. Interviews were audio-recorded and transcribed, and transcripts were analyzed using thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 20 participants, the median age was 37.5\u00a0years (IQR 32, 48), with\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096 (30%) identifying as Black and\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095 (25%) as Hispanic. Sixty-five percent of women had protective drug levels based on real-time tenofovir-diphosphate drug level assays at the study visit prior to their interviews. Some partners played a significant role in PrEP adherence, often showing support by vocalizing encouragement and appreciation, offering reminders to take PrEP, and sometimes administering PrEP. Other partners were unsupportive and discouraged PrEP use, which may have hindered adherence. HIV and PrEP stigma were identified as potential barriers for women to take PrEP and disclose their PrEP use to others.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Within the context of this PrEP demonstration project, partner dynamics impacted PrEP adherence for HIV-negative cisgender women in serodiscordant relationships. We urge further investigation of relationship dynamics and PrEP adherence and persistence specifically among US-based cisgender women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10461-025-05008-y","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:12:53Z","timestamp":1769152373000},"page":"1823-1833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PrEP as a \u201cHidden Message\u201d: The Impact of Partner Dynamics on Oral PrEP Adherence Among Cisgender Women in Serodiscordant Relationships"],"prefix":"10.1007","volume":"30","author":[{"given":"Thupten D.","family":"Phuntsog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamila K.","family":"Stockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rivet","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Kofron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael J.","family":"Landovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffanie","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2307-9108","authenticated-orcid":false,"given":"Jill","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"1","key":"5008_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25225","volume":"22","author":"E Nakku-Joloba","year":"2019","unstructured":"Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, et al. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples. J Int AIDS Soc. 2019;22(1):e25225. https:\/\/doi.org\/10.1002\/jia2.25225.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"5008_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., Sukalac, T., Thomas, V. T., Hart, C., \u2026 TDF2 Study Group","year":"2012","unstructured":"Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L. I., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., Sukalac, T., Thomas, V. T., Hart, C., \u2026 TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1110711.","journal-title":"N Engl J Med"},{"key":"5008_CR3","unstructured":"Food and Drug Administration (FDA). FDA Approves First Medication to Reduce HIV Risk.http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm311821.htm. Published July 16, 2012."},{"key":"5008_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001879","author":"JR Raifman","year":"2019","unstructured":"Raifman JR, Schwartz SR, Sosnowy CD, Montgomery MC, Almonte A, Bazzi AR, et al. Brief report: pre-exposure prophylaxis awareness and use among cisgender women at a sexually transmitted disease clinic. JAIDS J Acquir Immune Defic Syndr. 2019. https:\/\/doi.org\/10.1097\/QAI.0000000000001879.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5008_CR5","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report 2016. Atlanta, GA; 2017.\u00a0https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2016-vol-28.pdf."},{"key":"5008_CR6","unstructured":"AIDSVu. Mapping PrEP: First Ever Data on PrEP Users Across the U.S. 2018 https:\/\/aidsvu.org\/prep\/."},{"key":"5008_CR7","unstructured":"Centers for Disease Control and Prevention. HIV surveil- lance report: Diagnoses of HIV infection in the United States and dependent areas, 2015 27. www.cdc.gov\/hiv\/library\/reports\/surveillance."},{"issue":"8","key":"5008_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/apc.2017.0098","volume":"31","author":"AR Bazzi","year":"2017","unstructured":"Bazzi AR, Leech AA, Biancarelli DL, Sullivan M, Drainoni ML. Experiences using pre-exposure prophylaxis for safer conception among HIV serodiscordant heterosexual couples in the United States. AIDS Patient Care STDs. 2017;31(8):348\u201355.","journal-title":"AIDS Patient Care STDs"},{"key":"5008_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/2331205X.2018.1475124","author":"C Ishiekwene","year":"2018","unstructured":"Ishiekwene C, Thomas-Powell S, Ghitan M, Kuhn-Basti M, Chapnick E, Lin YS. Evaluation of the awareness, knowledge and use of pre-exposure prophylaxis (PrEP) among the serodiscordant partners of HIV infected individuals on ART in an urban HIV clinic. Cogent Med. 2018. https:\/\/doi.org\/10.1080\/2331205X.2018.1475124.","journal-title":"Cogent Med"},{"issue":"1","key":"5008_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/sextrans-2011-050114","volume":"88","author":"H Chemaitelly","year":"2012","unstructured":"Chemaitelly H, Cremin I, Shelton J, Hallett TB, Abu-Raddad LJ. Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sex Transm Infect. 2012;88(1):51\u20137. https:\/\/doi.org\/10.1136\/sextrans-2011-050114.","journal-title":"Sex Transm Infect"},{"issue":"6","key":"5008_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/13691058.2017.1367421","volume":"20","author":"RC Patel","year":"2018","unstructured":"Patel RC, Leddy AM, Odoyo J, Anand K, Stanford-Moore G, Wakhungu I, et al. What motivates serodiscordant couples to prevent HIV transmission within their relationships: findings from a PrEP implementation study in Kenya. Cult Health Sex. 2018;20(6):625\u201339. https:\/\/doi.org\/10.1080\/13691058.2017.1367421.","journal-title":"Cult Health Sex"},{"issue":"8","key":"5008_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002099","volume":"13","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLoS Med. 2016;13(8):e1002099. https:\/\/doi.org\/10.1371\/journal.pmed.1002099.","journal-title":"PLoS Med"},{"issue":"9687","key":"5008_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0140-6736(09)61118-1","volume":"374","author":"AD Smith","year":"2009","unstructured":"Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV\/AIDS in sub-Saharan Africa. Lancet (London, England). 2009;374(9687):416\u201322.","journal-title":"Lancet (London, England)"},{"issue":"4","key":"5008_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11904-014-0225-9","volume":"11","author":"KE Muessig","year":"2014","unstructured":"Muessig KE, Cohen MS. Advances in HIV prevention for serodiscordant couples. Curr HIV AIDS Rep. 2014;11(4):434\u201346. https:\/\/doi.org\/10.1007\/s11904-014-0225-9.","journal-title":"Curr HIV AIDS Rep"},{"issue":"2","key":"5008_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/QAI.0000000000002434","volume":"85","author":"R Stalter","year":"2020","unstructured":"Stalter R, Mugwanya K, Thomas K, Donnell D, Mujugira A, Ngure K, et al. Sexual behaviors after PrEP discontinuation among HIV serodiscordant couples in Kenya and Uganda. JAIDS J Acquir Immune Defic Syndr. 2020;85(2):174\u201381. https:\/\/doi.org\/10.1097\/QAI.0000000000002434.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"5008_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055060","volume":"8","author":"S Biraro","year":"2013","unstructured":"Biraro S, Ruzagira E, Kamali A, Whitworth J, Grosskurth H, Weiss HA. Hiv-1 transmission within marriage in rural Uganda: a longitudinal study. PLoS ONE. 2013;8(2):e55060. https:\/\/doi.org\/10.1371\/journal.pone.0055060.","journal-title":"PLoS ONE"},{"issue":"8","key":"5008_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000620","volume":"2","author":"JM McMahon","year":"2022","unstructured":"McMahon JM, Simmons J, Braksmajer A, LeBlanc N. HIV-serodifferent couples\u2019 perspectives and practices regarding HIV prevention strategies: a mixed methods study. PLoS Glob Public Health. 2022;2(8):e0000620. https:\/\/doi.org\/10.1371\/journal.pgph.0000620.","journal-title":"PLoS Glob Public Health"},{"issue":"9","key":"5008_CR18","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000730","volume":"8","author":"L Goparaju","year":"2017","unstructured":"Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers and costs: potential barriers to PrEP uptake among US women. J AIDS Clin Res. 2017;8(9):730. https:\/\/doi.org\/10.4172\/2155-6113.1000730.","journal-title":"J. AIDS Clin Res."},{"issue":"9","key":"5008_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/apc.2013.0302","volume":"28","author":"JM McMahon","year":"2014","unstructured":"McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, et al. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDs. 2014;28(9):462\u201374. https:\/\/doi.org\/10.1089\/apc.2013.0302.","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"5008_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/109019818801500401","volume":"15","author":"KR McLeroy","year":"1988","unstructured":"McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351\u201377. https:\/\/doi.org\/10.1177\/109019818801500401.","journal-title":"Health Educ Q"},{"issue":"2","key":"5008_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089118","volume":"9","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118. https:\/\/doi.org\/10.1371\/journal.pone.0089118.","journal-title":"PLoS ONE"},{"key":"5008_CR22","unstructured":"Centers for Disease Control and Prevention. 2025, February 15). Clinical Guidance for PrEP. https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html"},{"issue":"1","key":"5008_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11524-022-00711-w","volume":"100","author":"AS Miller","year":"2023","unstructured":"Miller AS, Krakower DS, Mayer KH. The potential of long-acting, injectable PrEP, and impediments to its uptake. J Urban Health. 2023;100(1):212\u20134. https:\/\/doi.org\/10.1007\/s11524-022-00711-w.","journal-title":"J Urban Health"},{"issue":"1","key":"5008_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/COH.0000000000000899","volume":"20","author":"RR Patel","year":"2025","unstructured":"Patel RR, Mayer KH. Why is roll-out of long-acting PrEP agents so slow? Curr Opin HIV AIDS. 2025;20(1):48\u201353. https:\/\/doi.org\/10.1097\/COH.0000000000000899.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"5008_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/cid\/ciab328","volume":"73","author":"J Blumenthal","year":"2021","unstructured":"Blumenthal J, Jain S, He F, Amico KR, Kofron R, Ellorin E, et al. Results from a pre-exposure prophylaxis demonstration project for at-risk cisgender women in the United States. Clin Infect Dis: off Publ Infect Dis Soc Am. 2021;73(7):1149\u201356. https:\/\/doi.org\/10.1093\/cid\/ciab328.","journal-title":"Clin Infect Dis: off. Publ. Infect. Dis. Soc. Am."},{"issue":"1","key":"5008_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12874-018-0594-7","volume":"18","author":"K Vasileiou","year":"2018","unstructured":"Vasileiou K, Barnett J, Thorpe S, Young T. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Med Res Methodol. 2018;18(1):148. https:\/\/doi.org\/10.1186\/s12874-018-0594-7.","journal-title":"BMC Med Res Methodol"},{"key":"5008_CR27","volume-title":"Qualitative Methods for Health Research","author":"J Green","year":"2009","unstructured":"Green J, Thorogood N. Qualitative Methods for Health Research. Sage; 2009."},{"key":"5008_CR28","volume-title":"Transforming qualitative information: thematic analysis and code development","author":"R Boyatzis","year":"1998","unstructured":"Boyatzis R. Transforming qualitative information: thematic analysis and code development. USA: Sage Publications; 1998."},{"issue":"2","key":"5008_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"5008_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/1609406917733847","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017. https:\/\/doi.org\/10.1177\/1609406917733847.","journal-title":"Int J Qual Methods"},{"issue":"1","key":"5008_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01710-17","volume":"62","author":"PL Anderson","year":"2017","unstructured":"Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2017;62(1):e01710-17. https:\/\/doi.org\/10.1128\/AAC.01710-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5008_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"RW Eisinger","year":"2019","unstructured":"Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: Undetectable Equals Untransmittable. JAMA. 2019;321(5):451\u20132. https:\/\/doi.org\/10.1001\/jama.2018.21167.","journal-title":"JAMA"},{"issue":"7","key":"5008_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/13691058.2017.1380230","volume":"20","author":"M Thomann","year":"2018","unstructured":"Thomann M, Grosso A, Zapata R, Chiasson MA. \u201cwtf is PrEP?\u201d: Attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Cult Health Sex. 2018;20(7):772\u201386. https:\/\/doi.org\/10.1080\/13691058.2017.1380230.","journal-title":"Cult Health Sex"},{"issue":"6","key":"5008_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s10508-020-01683-1","volume":"49","author":"KG Quinn","year":"2020","unstructured":"Quinn KG, Zarwell M, John SA, Christenson E, Walsh JL. Perceptions of PrEP use within primary relationships among young Black gay, bisexual, and other men who have sex with men. Arch Sex Behav. 2020;49(6):2117\u201328. https:\/\/doi.org\/10.1007\/s10508-020-01683-1.","journal-title":"Arch Sex Behav"},{"issue":"6","key":"5008_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/13691058.2022.2099016","volume":"25","author":"TL O'Malley","year":"2023","unstructured":"O\u2019Malley TL, Krier SE, Bainbridge M, Hawk ME, Egan JE, Burke JG. Women\u2019s perspectives on barriers to potential PrEP uptake for HIV prevention: HIV risk assessment, relationship dynamics and stigma. Cult Health Sex. 2023;25(6):776\u201390. https:\/\/doi.org\/10.1080\/13691058.2022.2099016.","journal-title":"Cult Health Sex"},{"issue":"5","key":"5008_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11524-019-00396-8","volume":"97","author":"C Lelutiu-Weinberger","year":"2020","unstructured":"Lelutiu-Weinberger C, Wilton L, Koblin BA, Hoover DR, Hirshfield S, Chiasson MA, et al. The role of social support in HIV testing and PrEP awareness among young Black men and transgender women who have sex with men or transgender women. J Urban Health. 2020;97(5):715\u201327. https:\/\/doi.org\/10.1007\/s11524-019-00396-8.","journal-title":"J Urban Health"},{"issue":"6","key":"5008_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286071","volume":"18","author":"NF Nogueira","year":"2023","unstructured":"Nogueira NF, Luisi N, Salazar AS, Cherenack EM, Raccamarich P, Klatt NR, et al. PrEP awareness and use among reproductive age women in Miami, Florida. PLoS ONE. 2023;18(6):e0286071. https:\/\/doi.org\/10.1371\/journal.pone.0286071.","journal-title":"PLoS ONE"},{"issue":"1","key":"5008_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.9745\/GHSP-D-19-00347","volume":"8","author":"J Pintye","year":"2020","unstructured":"Pintye J, Rogers Z, Kinuthia J, Mugwanya KK, Abuna F, Lagat H, et al. Two-way short message service (SMS) communication may increase pre-exposure prophylaxis continuation and adherence among pregnant and postpartum women in Kenya. Glob Health Sci Pract. 2020;8(1):55\u201367. https:\/\/doi.org\/10.9745\/GHSP-D-19-00347.","journal-title":"Glob Health Sci Pract"},{"issue":"5","key":"5008_CR39","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s40615-023-01729-9","volume":"11","author":"F Smit","year":"2024","unstructured":"Smit F, Masvawure TB. Barriers and facilitators to acceptability and uptake of Pre-Exposure Prophylaxis (PrEP) among Black women in the United States: a systematic review. J Racial Ethn Health Disparities. 2024;11(5):2649\u201362. https:\/\/doi.org\/10.1007\/s40615-023-01729-9.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"6","key":"5008_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/apc.2016.0098","volume":"30","author":"A Braksmajer","year":"2016","unstructured":"Braksmajer A, Senn TE, McMahon J. The potential of pre-exposure prophylaxis for women in violent relationships. AIDS Patient Care STDs. 2016;30(6):274\u201381. https:\/\/doi.org\/10.1089\/apc.2016.0098.","journal-title":"AIDS Patient Care STDs"},{"issue":"5","key":"5008_CR41","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s10461-019-02743-x","volume":"24","author":"TL O'Malley","year":"2020","unstructured":"O\u2019Malley TL, Hawk ME, Egan JE, Krier SE, Burke JG. Intimate partner violence and Pre-exposure Prophylaxis (PrEP): a rapid review of current evidence for women\u2019s HIV prevention. AIDS Behav. 2020;24(5):1342\u201357. https:\/\/doi.org\/10.1007\/s10461-019-02743-x.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-05008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-05008-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-05008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:16:25Z","timestamp":1782400585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-05008-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-05008-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"13 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jill Blumenthal receives research funding and served on Scientific Advisory Boards for Gilead Sciences. Raphy Landovitz serves on Scientific Advisory Boards and Consultant to ViiV and Merck.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research protocol for this study was approved by the Institutional Review Boards at the University of California Los Angeles and the University of California San Diego. All participants provided written informed consents prior to participation. In addition, each participant was provided a Notice of Privacy Practices booklet and a Health Insurance Portability and Accountability Act (HIPAA) Authorization form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided written informed consents prior to participation. In addition, each participant was provided a Notice of Privacy Practices booklet and a Health Insurance Portability and Accountability Act (HIPAA) Authorization form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}